Effectiveness of Coenzyme Q10 and Probiotics in Periodontal Therapy During Pregnancy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Pavia

About this trial

This randomized controlled clinical trial aims to evaluate the effectiveness of adjunctive coenzyme Q10 and probiotic supplementation (Limosilactobacillus reuteri Prodentis®) in improving periodontal health in pregnant women undergoing non-surgical periodontal therapy. Forty participants will be randomly assigned to two groups: the test group will receive professional oral hygiene every three months along with a coenzyme Q10-based toothpaste and daily probiotic supplementation; the control group will follow the same protocol without probiotics. The primary outcome is the reduction of the Plaque Index (PI), while secondary outcomes include Bleeding on Probing (BoP), Probing Pocket Depth (PPD), Clinical Attachment Level (CAL), gingival inflammation (MGI, PMGI), plaque distribution (PCR%, API), and gingival recession (R). The study duration is 6 months. The goal is to assess whether this combined therapy can promote a balanced oral microbiota and enhance periodontal health during pregnancy.

Eligibility criteria

Qualifiers

Pregnant women between the 4th and 8th month of gestation

Age ≥ 18 years

Able to understand and communicate in Italian and/or English

Willing to provide written informed consent

Disqualifiers

Presence of cardiac pacemakers

Diagnosed psychological, neurological, or psychiatric disorders

Ongoing oncological therapy

Use of bisphosphonates within the last 12 months

Trial design

Treatments tested in this trial

  • Limosilactobacillus reuteri Prodentis®
  • Coenzyme Q10 Toothpaste

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators